414 related articles for article (PubMed ID: 21902666)
1. Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases.
Srivastava S; Haigis MC
Curr Pharm Des; 2011; 17(31):3418-33. PubMed ID: 21902666
[TBL] [Abstract][Full Text] [Related]
2. Multifaced role of protein deacetylase sirtuins in neurodegenerative disease.
Gupta R; Ambasta RK; Kumar P
Neurosci Biobehav Rev; 2022 Jan; 132():976-997. PubMed ID: 34742724
[TBL] [Abstract][Full Text] [Related]
3. Neuronal protection by sirtuins in Alzheimer's disease.
Anekonda TS; Reddy PH
J Neurochem; 2006 Jan; 96(2):305-13. PubMed ID: 16219030
[TBL] [Abstract][Full Text] [Related]
4. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol--a boon for treating Alzheimer's disease?
Anekonda TS
Brain Res Rev; 2006 Sep; 52(2):316-26. PubMed ID: 16766037
[TBL] [Abstract][Full Text] [Related]
7. Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective.
Yeong KY; Berdigaliyev N; Chang Y
ACS Chem Neurosci; 2020 Dec; 11(24):4073-4091. PubMed ID: 33280374
[TBL] [Abstract][Full Text] [Related]
8. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
Belaidi AA; Bush AI
J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
[TBL] [Abstract][Full Text] [Related]
9. Effects of caloric restriction on cardiac oxidative stress and mitochondrial bioenergetics: potential role of cardiac sirtuins.
Shinmura K
Oxid Med Cell Longev; 2013; 2013():528935. PubMed ID: 23577224
[TBL] [Abstract][Full Text] [Related]
10. Sirtuins in cognitive ageing and Alzheimer's disease.
Braidy N; Jayasena T; Poljak A; Sachdev PS
Curr Opin Psychiatry; 2012 May; 25(3):226-30. PubMed ID: 22327552
[TBL] [Abstract][Full Text] [Related]
11. Modulation of sirtuins: new targets for antiageing.
Pallàs M; Verdaguer E; Tajes M; Gutierrez-Cuesta J; Camins A
Recent Pat CNS Drug Discov; 2008 Jan; 3(1):61-9. PubMed ID: 18221243
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
[TBL] [Abstract][Full Text] [Related]
13. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
Albani D; Polito L; Forloni G
J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction.
Duan W; Ross CA
Curr Drug Targets; 2010 Oct; 11(10):1281-92. PubMed ID: 20840070
[TBL] [Abstract][Full Text] [Related]
15. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
Huber K; Superti-Furga G
Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration.
Deza-Ponzio R; Herrera ML; Bellini MJ; Virgolini MB; Hereñú CB
Neurotoxicology; 2018 Sep; 68():19-24. PubMed ID: 29936317
[TBL] [Abstract][Full Text] [Related]
17. The sirtuins, oxidative stress and aging: an emerging link.
Merksamer PI; Liu Y; He W; Hirschey MD; Chen D; Verdin E
Aging (Albany NY); 2013 Mar; 5(3):144-50. PubMed ID: 23474711
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Sirtuins in Parkinson's Disease.
He L; Wang J; Yang Y; Li J; Tu H
Neurochem Res; 2022 Jun; 47(6):1491-1502. PubMed ID: 35220492
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin deacetylases in neurodegenerative diseases of aging.
Herskovits AZ; Guarente L
Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
Gan L
Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
